Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program

Background: Chemotherapy, anti-HER2 and PD-1 antibodies are standard treatments but only a minority of patients derive long-term benefit from these agents. Methods: In this report we describe the mutational landscape and outcome of patients with gastroesophageal cancers enroled in the ProfiLER progr...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Philippe A. Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort, Nathalie Marques, Michel Rivoire, Aurélien Dupré, Patrice Peyrat, Catherine Terret, Isabelle Ray-Coquard, Clélia Coutzac, David Pérol, Jean-Yves Blay, Olivier Trédan, Christelle de la Fouchardière
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2022-01-01
Serier:	Translational Oncology
Fag:	Oesophageal cancer Gastric cancer Molecular alterations, molecular-targeted agents NGS CGH
Online adgang:	http://www.sciencedirect.com/science/article/pii/S1936523321002576
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!